TP
BSX icon

Tranquility Partners’s Boston Scientific BSX Stock Holding History

Tranquility Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,454
Closed -$234K – 230
2025
Q4 		$234K Sell
2,454
-1,029
-30% -$101K 0.08% 209
2025
Q3 		$340K Sell
3,483
-1,037
-23% -$107K 0.11% 174
2025
Q2 		$485K Sell
4,520
-61
-1% -$6.17K 0.17% 133
2025
Q1 		$462K Sell
4,581
-399
-8% -$40.2K 0.18% 131
2024
Q4 		$445K Sell
4,980
-69
-1% -$6.07K 0.17% 137
2024
Q3 		$423K Sell
5,049
-243
-5% -$19.2K 0.15% 145
2024
Q2 		$408K Hold
5,292
– – 0.16% 145
2024
Q1 		$362K Sell
5,292
-69
-1% -$4.44K 0.14% 153
2023
Q4 		$310K Buy
5,361
+120
+2% +$6.41K 0.13% 156
2023
Q3 		$277K Hold
5,241
– – 0.12% 172
2023
Q2 		$283K Hold
5,241
– – 0.12% 169
2023
Q1 		$262K Hold
5,241
– – 0.12% 170
2022
Q4 		$243K Sell
5,241
-6,119
-54% -$265K 0.12% 176
2022
Q3 		$440K Buy
11,360
+81
+0.7% +$3.25K 0.24% 110
2022
Q2 		$420K Buy
11,279
+121
+1% +$4.92K 0.22% 123
2022
Q1 		$494K Buy
11,158
+232
+2% +$10.1K 0.23% 111
2021
Q4 		$464K Buy
10,926
+385
+4% +$16.2K 0.21% 112
2021
Q3 		$457K Sell
10,541
-4,591
-30% -$203K 0.23% 114
2021
Q2 		$647K Buy
15,132
+240
+2% +$10.1K 0.36% 83
2021
Q1 		$576K Buy
14,892
+9,260
+164% +$350K 0.36% 90
2020
Q4 		$202K Hold
5,632
– – 0.14% 163
2020
Q3 		$215K Sell
5,632
-163
-3% -$6.28K 0.18% 136
2020
Q2 		$203K Buy
+5,795
New +$209K 0.19% 135
2020
Q1 		– Sell
-10,745
Closed -$486K – 135
2019
Q4 		$486K Buy
10,745
+440
+4% +$18.4K 0.44% 70
2019
Q3 		$419K Hold
10,305
– – 0.44% 72
2019
Q2 		$443K Buy
+10,305
New +$396K 0.48% 64

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tranquility Partners's BSX Position: Q1 2026 in Review

Tranquility Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,454 shares — an estimated $234K sold.

Tranquility Partners first reported a position in BSX in Q2 2019 and held it in 26 quarters. The position peaked at $647K in Q2 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tranquility Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Tranquility Partners sold 2,454 Boston Scientific shares in Q1 2026, an estimated $234K.
  • Tranquility Partners first reported a position in Boston Scientific in Q2 2019 and held it in 26 quarters.
  • Tranquility Partners's Boston Scientific position peaked at $647K in Q2 2021.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tranquility Partners's 13F filing for Q1 2026, filed 20 Apr 2026.